Inhibition of IkappaBalpha nuclear export as an approach to abrogate nuclear factor-kappaB-dependent cancer cell

Shelby O'Connor1, Stuart Shumway, Shigeki Miyamoto

  • 1Program in Cellular and Molecular Biology, Department of Pharmacology, University of Wisconsin-Madison, 3795 Medical Sciences Center, 1300 University Avenue, Madison, WI 53706, USA.

Insights

Targeting IkappaBalpha nuclear export offers a broad strategy to inhibit nuclear factor-kappaB (NF-kappaB) in cancer. This approach reduces constitutive NF-kappaB activity, promoting apoptosis in various cancer cell types.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Constitutive activation of nuclear factor-kappaB (NF-kappaB) is common in human cancers, promoting malignant cell survival.
  • NF-kappaB deregulation can occur through diverse mechanisms, complicating general therapeutic strategies.
  • Inhibiting NF-kappaB is a promising anticancer approach due to its role in cancer cell survival.

Purpose of the Study:

  • To investigate the potential of inhibiting IkappaBalpha nuclear export as a general strategy to abrogate constitutive NF-kappaB activity in cancer.
  • To explore the downstream effects of blocking IkappaBalpha nuclear export on cancer cell signaling and survival.

Main Methods:

  • Utilized cancer cell models with constitutive NF-kappaB activity.
  • Intervened with the nuclear export of IkappaBalpha.
  • Assessed changes in NF-kappaB/IkappaBalpha complex localization and stability.
  • Monitored NF-kappaB transcriptional activity and induction of apoptosis.

Main Results:

  • Inhibition of IkappaBalpha nuclear export increased stable nuclear NF-kappaB/IkappaBalpha complexes.
  • This inhibition led to a reduction in constitutive NF-kappaB activity.
  • The observed effects resulted in the subsequent induction of apoptosis in cancer cells.
  • These findings were consistent across multiple cancer cell types.

Conclusions:

  • Inhibition of IkappaBalpha nuclear export represents a viable therapeutic target for broadly abrogating constitutive NF-kappaB activity in diverse cancers.
  • This strategy effectively reduces NF-kappaB signaling and induces apoptosis, irrespective of upstream deregulated events.
  • Targeting IkappaBalpha nuclear export offers a unified approach to combatting various cancers driven by NF-kappaB.

Related Concept Videos

Nuclear Export01:42

Nuclear Export

The nucleus restricts several proteins within and allows others to pass. The restricted proteins possess a nuclear retention sequence or NRS, anchoring them to the nuclear lamins and preventing their transport to the cytosol. The non-restricted proteins, after their synthesis, are transported to their site of action, such as the cytosol or other organelles, with the help of nuclear export signals or NES.
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...